Yahoo Web Search

Search results

1. • U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...

     Morningstar· 2 days ago

     Approval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 ...

2. • 

     Previously Unknown Immune System Link Uncovered – Findings Could Lead to New Cancer Treatments

     SciTechDaily· 3 days ago

     Weill Cornell scientists discovered a crucial link between two immune pathways involving IL-23 and...

3. • Baysient® Launches Therapeutic Drug Monitoring Software for Oncology Biologics

     Benzinga· 2 days ago

     Baysient®, a leading provider of therapeutic drug monitoring (TDM) software, today announced the launch of TuMinimize™, a web-based nomogram/algorithm designed to optimize the dosing of oncology ...

4. • 

     What's in a Name: Defining Difficult-to-Treat axSpA and PsA

     Medscape· 7 days ago

     Despite an expanding arsenal of disease-modifying antirheumatic drugs (DMARDs), many patients with...

5. • 

     Why Is My Skin So Itchy?

     Verywell Health via Yahoo News· 2 days ago

     Pruritus, or itchy skin, is a characteristic feature of many skin diseases and an unusual sign of some systemic diseases. It can be painful or...

6. • States struggle to help patients navigate insurance hurdle known as 'step therapy'

     Medical Xpress· 7 hours ago

     Cassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a teenager growing up in northeastern Pennsylvania, she saw numerous neurologists and tried a variety ...

7. • 

     21 Celebrities Who Are Battling Rare Chronic Illnesses

     SheKnows via Yahoo News· 7 days ago

     Living with, treating and understanding the effects of a rare and/or chronic illness is a serious...

8. • AbbVie (NYSE:ABBV) Shares Up 0%

     ETF DAILY NEWS· 5 days ago

     Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0% during mid-day trading on Thursday . The company traded as high as $166.45 and last traded at $166.15. ABBV has been the topic ...

9. • 

     Jude Bellingham fans discuss hyperpigmentation over footballer's appearance

     Yahoo Life UK· 1 day ago

     "Studies show that sunscreen containing iron oxide is significantly more effective in the treatment...

10. • 

      Here Comes the Sun: We Are Your Summer Skincare Experts

      Lancaster Online· 14 hours ago

      Summer is finally here and, for most of us, that means more time in the sun - whether it’s relaxing...